• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏压塞患者的临床特征与预后:三级医疗中心的5年经验

Clinical characteristics and prognosis of cardiac tamponade patients: 5‑year experience at a tertiary center.

作者信息

Kızıltunç E, Ünlü S, Yakıcı İ E, Kundi H, Korkmaz A, Çetin M, Örnek E

机构信息

Cardiology Department, Numune Education and Research Hospital, 06100, Ankara, Turkey.

Cardiology Department, Atatürk Chest Diseases and Chest Surgery Education and Research Hospital, Ankara, Turkey.

出版信息

Herz. 2020 Nov;45(7):676-683. doi: 10.1007/s00059-018-4769-0. Epub 2018 Nov 23.

DOI:10.1007/s00059-018-4769-0
PMID:30470911
Abstract

BACKGROUND

Cardiac tamponade (CT) is characterized by compression of the cardiac chambers due to pericardial fluid accumulation. The etiology and prognosis may vary in different regions, and thus patient series from various regions can be useful for exploring the etiological and prognostic disparities. The aim of this study was to determine the clinical characteristics of patients with imminent CT, to evaluate the diagnostic performance of biochemical, microbiologic, and pathologic laboratory analysis, and to ascertain the prognosis of CT patients.

METHODS

We enrolled all patients with imminent CT who underwent percutaneous pericardiocentesis between July 2012 and December 2017 in this retrospective study. The patients were classified into three etiology groups: (a) malignancy (MRCT); (b) iatrogenic/mechanical complication of myocardial infarction (IMCT); and (c) other causes (OCT). Clinical information, laboratory findings, and survival data were recorded.

RESULTS

In total, 186 pericardiocentesis procedures were performed on 153 consecutive patients with CT. The median follow-up was 137 days (range: 1-1937). The MRCT group had the highest mortality rate (79%) in 12 months, while the OCT group had the lowest rate (27%). We determined that increased age, higher serum urea levels, and malignancy-related CT were independent predictors of mortality. The mortality rates of the MRCT and IMCT groups were similar, with both of them being significantly higher than the rate of the OCT group. In all, 15 patients were diagnosed with a new malignancy via pericardial fluid cytology.

CONCLUSION

Patients in the MRCT and IMCT groups had a poor prognosis. The presence of malignancy was found to be the most powerful predictor of mortality in CT patients.

摘要

背景

心脏压塞(CT)的特征是心包积液导致心腔受压。不同地区的病因和预后可能有所不同,因此来自不同地区的患者系列对于探索病因和预后差异可能有用。本研究的目的是确定即将发生CT的患者的临床特征,评估生化、微生物学和病理学实验室分析的诊断性能,并确定CT患者的预后。

方法

在这项回顾性研究中,我们纳入了2012年7月至2017年12月期间接受经皮心包穿刺术的所有即将发生CT的患者。患者被分为三个病因组:(a)恶性肿瘤(MRCT);(b)心肌梗死的医源性/机械性并发症(IMCT);(c)其他原因(OCT)。记录临床信息、实验室检查结果和生存数据。

结果

总共对153例连续的CT患者进行了186次心包穿刺术。中位随访时间为137天(范围:1 - 1937天)。MRCT组在12个月内的死亡率最高(79%),而OCT组最低(27%)。我们确定年龄增加、血清尿素水平升高和与恶性肿瘤相关的CT是死亡率的独立预测因素。MRCT组和IMCT组的死亡率相似,均显著高于OCT组。共有15例患者通过心包积液细胞学检查诊断为新发恶性肿瘤。

结论

MRCT组和IMCT组患者预后较差。发现恶性肿瘤的存在是CT患者死亡率的最有力预测因素。

相似文献

1
Clinical characteristics and prognosis of cardiac tamponade patients: 5‑year experience at a tertiary center.心脏压塞患者的临床特征与预后:三级医疗中心的5年经验
Herz. 2020 Nov;45(7):676-683. doi: 10.1007/s00059-018-4769-0. Epub 2018 Nov 23.
2
Evaluation of non-surgical causes of cardiac tamponade in children at a cardiac surgery center.在一家心脏外科中心对儿童心脏压塞的非手术病因进行评估。
Pediatr Int. 2014 Feb;56(1):13-8. doi: 10.1111/ped.12192.
3
CT-Guided Drainage of Pericardial Effusion after Open Cardiac Surgery.心脏直视手术后心包积液的CT引导下引流
Cardiovasc Intervent Radiol. 2017 Aug;40(8):1223-1228. doi: 10.1007/s00270-017-1624-2. Epub 2017 Mar 23.
4
Clinical and echocardiographic characteristics of pericardial effusion in patients who underwent echocardiographically guided pericardiocentesis: Yonsei Cardiovascular Center experience, 1993-2003.接受超声心动图引导心包穿刺术患者心包积液的临床和超声心动图特征:延世心血管中心经验,1993 - 2003年
Yonsei Med J. 2004 Jun 30;45(3):462-8. doi: 10.3349/ymj.2004.45.3.462.
5
The role of early contrast-enhanced chest computed tomography in the aetiological diagnosis of patients presenting with cardiac tamponade or large pericardial effusion.早期对比增强胸部计算机断层扫描在心脏压塞或大量心包积液患者病因诊断中的作用。
Eur Heart J Cardiovasc Imaging. 2016 Apr;17(4):421-8. doi: 10.1093/ehjci/jev225. Epub 2015 Sep 15.
6
Echocardiographically guided pericardiocentesis - the gold standard for the management of pericardial effusion and cardiac tamponade.超声心动图引导下的心包穿刺术——心包积液和心脏压塞治疗的金标准。
Can J Cardiol. 1999 Nov;15(11):1251-5.
7
Percutaneous pericardiocentesis versus subxiphoid pericardiotomy in cardiac tamponade due to postoperative pericardial effusion.术后心包积液所致心脏压塞中行经皮心包穿刺术与剑突下心包切开术的比较
J Cardiothorac Vasc Anesth. 1993 Apr;7(2):178-83. doi: 10.1016/1053-0770(93)90213-5.
8
Comparison of Pericardiocentesis in Post-Cardiac Surgery and Nonsurgical Patients with Pericardial Tamponade.心脏手术后与非心脏手术后心包填塞患者心包穿刺术的比较。
Braz J Cardiovasc Surg. 2022 Aug 16;37(4):488-492. doi: 10.21470/1678-9741-2020-0714.
9
Role of echocardiography in the treatment of cardiac tamponade.超声心动图在心脏压塞治疗中的作用。
Echocardiography. 2014 Aug;31(7):899-910. doi: 10.1111/echo.12605. Epub 2014 Apr 4.
10
Changes in QRS voltage in cardiac tamponade and pericardial effusion: reversibility after pericardiocentesis and after anti-inflammatory drug treatment.心脏压塞和心包积液时QRS电压的变化:心包穿刺术后及抗炎药物治疗后的可逆性
J Am Coll Cardiol. 2001 Jul;38(1):219-26. doi: 10.1016/s0735-1097(01)01313-4.

引用本文的文献

1
Is pulmonary hypertension protective against cardiac tamponade? A systematic review.肺动脉高压是否对心脏压塞有保护作用?系统评价。
Intern Emerg Med. 2024 Oct;19(7):1987-2003. doi: 10.1007/s11739-024-03566-y. Epub 2024 Apr 15.
2
Cardiac tamponade.心脏压塞。
Nat Rev Dis Primers. 2023 Jul 20;9(1):36. doi: 10.1038/s41572-023-00446-1.
3
Anagrelide-induced pericardial effusion in a patient with essential thrombocythemia.一名原发性血小板增多症患者出现阿那格雷诱导的心包积液。
Clin Case Rep. 2023 Apr 23;11(4):e7246. doi: 10.1002/ccr3.7246. eCollection 2023 Apr.
4
The Prognostic Impact of Pericardial Fluid Cytology in Malignant Pericardial Effusion.心包积液细胞病理学检查对恶性心包积液的预后影响。
Anatol J Cardiol. 2023 Jan;27(1):41-46. doi: 10.14744/AnatolJCardiol.2022.2050.
5
Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma.化学难治性霍奇金淋巴瘤患者质子治疗期间的心包积液
Int J Part Ther. 2021 Oct 18;8(4):76-81. doi: 10.14338/IJPT-21-00010. eCollection 2022 Spring.